Intravitreal enzyme replacement therapy to prevent retinal disease progression in children with neuronal ceroid lipofuscinosis type 2 (CLN2): Unilateral injection results

被引：0
|
作者：
Rogers, David L. [1 ]
de los Reyes, Emily C. [1 ]
Mendel, Thomas A. [2 ]
Caprul, Brian J. [1 ]
Podlasiak, Sarah [1 ]
Jordan, Catherine O. [1 ]
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.108019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
280
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
    Nickel, Miriam
    Simonati, Alessandro
    Jacoby, David
    Lezius, Susanne
    Kilian, Dirk
    Van de Graaf, Benjamin
    Pagovich, Odelya E.
    Kosofsky, Barry
    Yohay, Kaleb
    Downs, Matthew
    Slasor, Peter
    Aiayi, Temitayo
    Crystal, Ronald G.
    Kohlschuetter, Alfried
    Sondhi, Dolan
    Schulz, Angela
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (08): : 582 - 590
  • [22] Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
    Dyke, J. P.
    Sondhi, D.
    Voss, H. U.
    Yohay, K.
    Hollmann, C.
    Mancenido, D.
    Kaminsky, S. M.
    Heier, L. A.
    Rudser, K. D.
    Kosofsky, B.
    Casey, B. J.
    Crystal, R. G.
    Balton, D.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (06) : 1160 - 1169
  • [23] Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay
    Ardicli, Didem
    Haliloglu, Goknur
    Gocmen, Rahsan
    Gunbey, Ceren
    Topcu, Meral
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2021, 33 : 94 - 98
  • [24] Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis
    Fietz, Michael
    AlSayed, Moeenaldeen
    Burke, Derek
    Cohen-Pfeffer, Jessica
    Cooper, Jonathan D.
    Dvorakova, Lenka
    Giugliani, Roberto
    Izzo, Emanuela
    Jahnova, Helena
    Lukacs, Zoltan
    Mole, Sara E.
    de Halac, Ines Noher
    Pearce, David A.
    Poupetova, Helena
    Schulz, Angela
    Specchio, Nicola
    Xin, Winnie
    Miller, Nicole
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (1-2) : 160 - 167
  • [25] Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression
    Katz, M. L.
    Johnson, G. C.
    Leach, S. B.
    Williamson, B. G.
    Coates, J. R.
    Whiting, R. E. H.
    Vansteenkiste, D. P.
    Whitney, M. S.
    GENE THERAPY, 2017, 24 (04) : 215 - 223
  • [26] Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression
    M L Katz
    G C Johnson
    S B Leach
    B G Williamson
    J R Coates
    R E H Whiting
    D P Vansteenkiste
    M S Whitney
    Gene Therapy, 2017, 24 : 215 - 223
  • [27] Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis
    Vuillemenot, Brian R.
    Kennedy, Derek
    Cooper, Jonathan D.
    Wong, Andrew M. S.
    Sri, Sarmi
    Doeleman, Thom
    Katz, Martin L.
    Coates, Joan R.
    Johnson, Gayle C.
    Reed, Randall P.
    Adams, Eric L.
    Butt, Mark T.
    Musson, Donald G.
    Henshaw, Joshua
    Keve, Steve
    Cahayag, Rhea
    Tsuruda, Laurie S.
    O'Neill, Charles A.
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : 281 - 293
  • [28] Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis
    Tracy, Christopher J.
    Whiting, Rebecca E. H.
    Pearce, Jacqueline W.
    Williamson, Baye G.
    Vansteenkiste, Daniella P.
    Gillespie, Lauren E.
    Castaner, Leilani J.
    Bryan, Jeffrey N.
    Coates, Joan R.
    Jensen, Cheryl A.
    Katz, Martin L.
    EXPERIMENTAL EYE RESEARCH, 2016, 152 : 77 - 87
  • [29] Novel surgical approach for intraventricular cerliponase alfa enzyme replacement therapy via central venous access device (CVAD) port in neuronal ceroid lipofuscinosis type 2 (CLN2) disease
    Scott Boop
    Dominic Nistal
    Adriel Barrios-Anderson
    W. Bruce Cherny
    Irene J. Chang
    Emily Shelkowitz
    Terry Kho
    Hannah E. Goldstein
    Jason Hauptman
    Child's Nervous System, 2025, 41 (1)
  • [30] Substrate specificity of CLN2 proteinase, the enzyme deficient in the late-infantile neuronal ceroid lipofuscinosis
    Junaid, MA
    Pullarkat, RG
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 : S14 - S14
12345